- Home
- CPOP vs INTS Comparison
CPOP vs INTS Comparison
Compare CPOP & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPOP
- INTS
- Stock Information
- Founded
- CPOP 2007
- INTS 2012
- Country
- CPOP China
- INTS United States
- Employees
- CPOP N/A
- INTS N/A
- Industry
- CPOP Services-Misc. Amusement & Recreation
- INTS Biotechnology: Pharmaceutical Preparations
- Sector
- CPOP Consumer Discretionary
- INTS Health Care
- Exchange
- CPOP Nasdaq
- INTS Nasdaq
- Market Cap
- CPOP 9.4M
- INTS 9.4M
- IPO Year
- CPOP 2021
- INTS 2023
- Fundamental
- Price
- CPOP $0.54
- INTS $0.32
- Analyst Decision
- CPOP
- INTS Strong Buy
- Analyst Count
- CPOP 0
- INTS 3
- Target Price
- CPOP N/A
- INTS $8.50
- AVG Volume (30 Days)
- CPOP 17.5K
- INTS 2.7M
- Earning Date
- CPOP 07-07-2025
- INTS 08-07-2025
- Dividend Yield
- CPOP N/A
- INTS N/A
- EPS Growth
- CPOP N/A
- INTS N/A
- EPS
- CPOP N/A
- INTS N/A
- Revenue
- CPOP $47,381,918.00
- INTS N/A
- Revenue This Year
- CPOP N/A
- INTS N/A
- Revenue Next Year
- CPOP N/A
- INTS N/A
- P/E Ratio
- CPOP N/A
- INTS N/A
- Revenue Growth
- CPOP 155.52
- INTS N/A
- 52 Week Low
- CPOP $0.46
- INTS $0.26
- 52 Week High
- CPOP $1.70
- INTS $5.10
- Technical
- Relative Strength Index (RSI)
- CPOP 40.67
- INTS 37.08
- Support Level
- CPOP $0.53
- INTS $0.28
- Resistance Level
- CPOP $0.59
- INTS $0.32
- Average True Range (ATR)
- CPOP 0.03
- INTS 0.06
- MACD
- CPOP -0.00
- INTS 0.01
- Stochastic Oscillator
- CPOP 9.88
- INTS 7.43
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.